Ads

 

Ads

 

Ads

 

Top Healthcare Companies in Europe List by Market Cap as on July-30-2023

Top Healthcare Companies in Europe List by Market Cap as on July-30-2023. Biggest and Top Healthcare Companies in Europe Companies by Market Cap. Largest Top Healthcare Companies in Europe List by Market Cap as on July-30-2023.
Metatag Title
Top Healthcare Companies in Europe
Metatag Abstract
Top Healthcare Companies in Europe, Biggest Healthcare Companies in Europe, Largest Healthcare Companies in Europe.
  1. Novo Nordisk A/S

    World Rank (Jan-05-2024)
    16
    Market Cap (Jan-05-2024)
    459.394 Billion USD
    World Rank (Jul-30-2023)
    24
    Market Cap (Jul-30-2023)
    356.920 Billion USD
    World Rank (Dec-25-2022)
    27
    Market Cap (Dec-25-2022)
    301.520 Billion USD
    World Rank (Jan-07-2022)
    50
    Market Cap (Jan-07-2022)
    231.35 Billion USD
    Annual Revenue in USD
    26,157 Million USD
    Annual Operating Income in USD
    11,058 Million USD
    Annual Net Income in USD
    8,208 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquarters is in Denmark.

    Novo Nordisk employs approximately 55,185 employees in 79 countries as on 2022 and markets its products in more than 170 countries.

    Facts About Company

    For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

    For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

  2. Roche Holding AG

    World Rank (Jan-05-2024)
    40
    Market Cap (Jan-05-2024)
    238.453 Billion USD
    World Rank (Jul-30-2023)
    38
    Market Cap (Jul-30-2023)
    249.730 Billion USD
    World Rank (Dec-25-2022)
    32
    Market Cap (Dec-25-2022)
    261.410 Billion USD
    World Rank (Jan-07-2022)
    25
    Market Cap (Jan-07-2022)
    356.15 Billion USD
    Annual Revenue in USD
    72,691 Million USD
    Annual Operating Income in USD
    20,068 Million USD
    Annual Net Income in USD
    14,267 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Roche Holding is  Healthcare Company having business in pharmaceuticals and diagnostics. The headquarters is in Switzerland. 

    Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Ophthalmology and Respiratory branches Medicines.

    Facts About Company

    Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

    Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

    As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

  3. AstraZeneca

    World Rank (Jan-05-2024)
    48
    Market Cap (Jan-05-2024)
    213.330 Billion USD
    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    Annual Revenue in USD
    44,351 Million USD
    Annual Operating Income in USD
    4,561 Million USD
    Annual Net Income in USD
    3,288 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, AstraZeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford. Headquarters is in UK.

    AstraZeneca Product Sales of 43,789 million USD split by Disease Area for year ending Dec-2023

    Facts About Company

    For year ending Dec-2023, AstraZeneca annual Total revenue was 45,811 million USD and annual operating profit was 8,193 million USD and annual net income was 5,961 million USD.

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,293 million USD for year ending Dec-2022.

    AstraZeneca has 89,900 employees as of 2023. 

  4. Novartis AG

    World Rank (Jan-05-2024)
    45
    Market Cap (Jan-05-2024)
    216.513 Billion USD
    World Rank (Jul-30-2023)
    45
    Market Cap (Jul-30-2023)
    220.820 Billion USD
    World Rank (Dec-25-2022)
    47
    Market Cap (Dec-25-2022)
    195.460 Billion USD
    World Rank (Jan-07-2022)
    61
    Market Cap (Jan-07-2022)
    201.26 Billion USD
    Annual Revenue in USD
    51,830 Million USD
    Annual Operating Income in USD
    9,190 Million USD
    Annual Net Income in USD
    6,950 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.

    Facts About Company

    Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

    Novartis had over 101,703 employees worldwide as on 2022.

    Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.

  5. Sanofi

    World Rank (Jan-05-2024)
    104
    Market Cap (Jan-05-2024)
    127.146 Billion USD
    World Rank (Jul-30-2023)
    97
    Market Cap (Jul-30-2023)
    130.890 Billion USD
    World Rank (Dec-25-2022)
    102
    Market Cap (Dec-25-2022)
    121.650 Billion USD
    World Rank (Jan-07-2022)
    116
    Market Cap (Jan-07-2022)
    126.37 Billion USD
    Annual Revenue in USD
    50,044 Million USD
    Annual Operating Income in USD
    13,099 Million USD
    Annual Net Income in USD
    7,409 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Sanofi is France based Multi-National Pharmacy company headquartered in Paris, France.

    Sanofi has 32 manufacturing sites in 32 countries. Sanofi provides healthcare solutions in more than 170 countries.

    Sanofi is listed in Paris (Euronext: SAN) and New York (Nasdaq: SNY).

    Facts About Company

    As on 2022, Sanofi had 91,573 employees across 100 countries.

    For year ending Dec-2022, Sanofi annual revenue was 45,389 million EUR and annual net income was 8,371 million EUR during the same period.

    As on 2022, Sanofi had 59 manufacturing sites and 20 R&D sites.

    Sanofi annual revenue for year ending Dec-2022 by Geographical Regions:

  6. Medtronic

    World Rank (Jan-05-2024)
    126
    Market Cap (Jan-05-2024)
    111.598 Billion USD
    World Rank (Jul-30-2023)
    118
    Market Cap (Jul-30-2023)
    117.410 Billion USD
    World Rank (Dec-25-2022)
    127
    Market Cap (Dec-25-2022)
    103.090 Billion USD
    World Rank (Jan-07-2022)
    95
    Market Cap (Jan-07-2022)
    141.39 Billion USD
    Annual Revenue in USD
    31,227 Million USD
    Annual Operating Income in USD
    5,830 Million USD
    Annual Net Income in USD
    3,758 Million USD
    Annual Results for Period Ending
    Apr-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Medtronic Plc is a healthcare company and manufactures medical equipment. Medtronic operates from more than 370 locations in approximately 160 countries. Headquarters is in Ireland.

    Facts About Company

    Medtronic Annual Revenues for year ending April 2023 was 31,227 Million USD and Net Income was 3,758 Million USD.

    Medtronic Annual Revenues for year ending April 2022 was 31,686 Million USD and Net Income was 5,039 Million USD.

    As on 2022, Medtronic has 95,000 full time equivalent employees.

  7. Essilor Luxottica

    World Rank (Jan-05-2024)
    166
    Market Cap (Jan-05-2024)
    89.569 Billion USD
    World Rank (Jul-30-2023)
    162
    Market Cap (Jul-30-2023)
    89.758 Billion USD
    World Rank (Dec-25-2022)
    163
    Market Cap (Dec-25-2022)
    81.138 Billion USD
    World Rank (Jan-07-2022)
    181
    Market Cap (Jan-07-2022)
    89.05 Billion USD
    Annual Revenue in USD
    27,006 Million USD
    Annual Operating Income in USD
    3,415 Million USD
    Annual Net Income in USD
    2,373 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Essilor Luxottica is Eyewear Company, Eyewear glasses wholesale distribution and retail company with headquarters is in Milan, Italy.

    As on Dec-2021, ESSILOR LUXOTTICA has 8,939 retail stores.

    For year ending Dec-2021 ESSILOR LUXOTTICA Annual Revenue was 19,820 Million EUR and Annual Net Income was 1,463 Million EUR.

    Facts About Company

    Essilor Luxottica annual revenue was 24,494 Million EUR and annual net income was 2,152 Million EUR for year ending Dec-2022.

    Essilor Luxottica annual revenue was 19,820 Million EUR and annual net income was 1,463 Million EUR for year ending Dec-2021.

    Essilor Luxottica had 151,017 employees as on May-2021.

  8. Merck Kgaa

    World Rank (Jan-05-2024)
    237
    Market Cap (Jan-05-2024)
    68.031 Billion USD
    World Rank (Jul-30-2023)
    191
    Market Cap (Jul-30-2023)
    76.867 Billion USD
    World Rank (Dec-25-2022)
    156
    Market Cap (Dec-25-2022)
    82.973 Billion USD
    World Rank (Jan-07-2022)
    150
    Market Cap (Jan-07-2022)
    102.50 Billion USD
    Annual Revenue in USD
    24,512 Million USD
    Annual Operating Income in USD
    5,239 Million USD
    Annual Net Income in USD
    3,667 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Merck is USA based healthcare and pharmaceutical multi-national company. Merck Company makes a difference in the lives of people globally through their innovative medicines, vaccines, and animal health products. Headquarters is in Germany.

    Facts About Company

    Merck annual revenue was 22,232 Million EUR and annual net income was 3,326 Million EUR for year ending Dec-2022.

    Merck annual revenue was 19,687 Million EUR and annual net income was 3,055 Million EUR for year ending Dec-2021.

    Merck had 64,232 employees as of 2022.

  9. Allergan

    World Rank (Jan-05-2024)
    200
    World Rank (Jul-30-2023)
    200
    World Rank (Dec-25-2022)
    200
    World Rank (Jan-07-2022)
    200
    Annual Revenue in USD
    16,080 Million USD
    Annual Results for Period Ending
    Dec-2019 ending year
    Headquarters Country
    Company Profile

    Allergan is Pharmaceutical and Healthcare company with headquarters is in Dublin, Ireland. As on 2019, Allergan has 17,400 employees and they serve across 100 nations.

    Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

    In 2020, AbbVie acquired Allergan for 63 billion USD.

  10. GSK plc

    World Rank (Jan-05-2024)
    179
    Market Cap (Jan-05-2024)
    80.265 Billion USD
    World Rank (Jul-30-2023)
    212
    Market Cap (Jul-30-2023)
    72.563 Billion USD
    World Rank (Dec-25-2022)
    185
    Market Cap (Dec-25-2022)
    72.099 Billion USD
    World Rank (Jan-07-2022)
    132
    Market Cap (Jan-07-2022)
    110.32 Billion USD
    Annual Revenue in USD
    37,666 Million USD
    Annual Operating Income in USD
    8,263 Million USD
    Annual Net Income in USD
    19,211 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.

    In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.

    Facts About Company

    GSK annual revenue was 29,324 Million GBP and annual net income was 14,956 Million GBP for year ending Dec-2022.

    GSK annual revenues for year ending Dec-2021 was 34,144 million GBP and annual operating income was 6,165 million GBP and annual net income of 4,385 million GBP.

    GSK had 70,000 employees as on 2022.

    As on 2021, GSK has over 90,000 employees across 92 countries and work directly with 37,500 suppliers.

Share

Ads